Guangxi Wuzhou Zhongheng Group, Ltd. operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Guangxi Wuzhou Zhongheng Group, Ltd. with three other
companies in this sector in China:
Jinhe Biotechnology Co Ltd
sales of 1.25 billion Chinese Renmimbi [US$184.75 million]
of which 90%
was Medical Feeds Additives),
Guilin Sanjin Pharmaceutical Co Ltd
(1.37 billion Chinese Renmimbi [US$202.72 million]
of which 96%
was Proprietary Chinese medicine), and
Shanghai Kaibao Pharmaceutical Company Limited
(1.40 billion Chinese Renmimbi [US$206.24 million]
of which 100%
During the year ended December of 2015, sales at
Guangxi Wuzhou Zhongheng Group, Ltd. were 1.34 billion Chinese Renmimbi (US$198.22 million).
decrease of 58.2%
versus 2014, when the company's sales were 3.21 billion Chinese Renmimbi.
The sales level in 2015 was fairly close to the level five years ago: in 2010, Guangxi Wuzhou Zhongheng Group, Ltd. had sales
of 1.43 billion Chinese Renmimbi.
Contributing to the drop in overall sales was the 71.8% decline
in Real Estate, from 85.54 million Chinese Renmimbi to 24.11 million Chinese Renmimbi.
There were also decreases in sales in
Pharmaceutical Segment (down 59.7% to 1.23 billion Chinese Renmimbi)
However, these declines were partially offset by the increase in sales of
Food Manufacturing (up 12.4% to 85.75 million Chinese Renmimbi)